TBPH Reports $266.6M YUPELRI Sales, $3.9B TRELEGY, $50M Milestone, $400M Cash, No Debt
Theravance Biopharma, Inc. · PHARMACEUTICAL PREPARATIONS · Now $15.94
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS